News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
725,185 Results
Type
Article (42899)
Company Profile (297)
Press Release (681988)
Multimedia
Podcasts (91)
Webinars (15)
Section
Business (210663)
Career Advice (2096)
Deals (36683)
Drug Delivery (107)
Drug Development (83254)
Employer Resources (175)
FDA (16665)
Job Trends (15447)
News (356636)
Policy (34023)
Tag
Academia (2601)
Accelerated approval (10)
Adcomms (23)
Allergies (101)
Alliances (51637)
ALS (113)
Alzheimer's disease (1465)
Antibody-drug conjugate (ADC) (163)
Approvals (16663)
Artificial intelligence (331)
Autoimmune disease (30)
Automation (19)
Bankruptcy (372)
Best Places to Work (11771)
BIOSECURE Act (20)
Biosimilars (129)
Biotechnology (188)
Bladder cancer (93)
Brain cancer (38)
Breast cancer (370)
Cancer (2927)
Cardiovascular disease (224)
Career advice (1759)
Career pathing (31)
CAR-T (188)
CDC (32)
Cell therapy (510)
Cervical cancer (22)
Clinical research (68524)
Collaboration (1050)
Company closure (3)
Compensation (699)
Complete response letters (29)
COVID-19 (2697)
CRISPR (63)
C-suite (339)
Cystic fibrosis (117)
Data (3035)
Decentralized trials (2)
Denatured (30)
Depression (64)
Diabetes (350)
Diagnostics (6511)
Digital health (23)
Diversity (9)
Diversity, equity & inclusion (45)
Drug discovery (143)
Drug pricing (135)
Drug shortages (31)
Duchenne muscular dystrophy (131)
Earnings (89182)
Editorial (42)
Employer branding (21)
Employer resources (151)
Events (116671)
Executive appointments (868)
FDA (18354)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (9)
Funding (946)
Gene editing (138)
Generative AI (24)
Gene therapy (392)
GLP-1 (832)
Government (4634)
Grass and pollen (5)
Guidances (182)
Healthcare (19030)
HIV (40)
Huntington's disease (31)
IgA nephropathy (41)
Immunology and inflammation (158)
Immuno-oncology (10)
Indications (40)
Infectious disease (2870)
Inflammatory bowel disease (153)
Inflation Reduction Act (10)
Influenza (62)
Intellectual property (122)
Interviews (323)
IPO (16870)
IRA (51)
Job creations (4068)
Job search strategy (1495)
Kidney cancer (13)
Labor market (53)
Layoffs (520)
Leadership (20)
Legal (8408)
Liver cancer (80)
Longevity (12)
Lung cancer (407)
Lymphoma (211)
Machine learning (11)
Management (59)
Manufacturing (408)
MASH (93)
Medical device (13551)
Medtech (13556)
Mergers & acquisitions (20531)
Metabolic disorders (875)
Multiple sclerosis (97)
NASH (18)
Neurodegenerative disease (121)
Neuropsychiatric disorders (34)
Neuroscience (2168)
NextGen: Class of 2025 (6643)
Non-profit (4536)
Now hiring (48)
Obesity (444)
Opinion (245)
Ovarian cancer (102)
Pain (120)
Pancreatic cancer (122)
Parkinson's disease (188)
Partnered (22)
Patents (308)
Patient recruitment (170)
Peanut (53)
People (59705)
Pharmaceutical (91)
Pharmacy benefit managers (23)
Phase I (21240)
Phase II (30128)
Phase III (22586)
Pipeline (1661)
Policy (215)
Postmarket research (2682)
Preclinical (9061)
Press Release (68)
Prostate cancer (141)
Psychedelics (38)
Radiopharmaceuticals (259)
Rare diseases (483)
Real estate (6271)
Recruiting (68)
Regulatory (23535)
Reports (50)
Research institute (2375)
Resumes & cover letters (359)
Rett syndrome (9)
RNA editing (9)
RSV (49)
Schizophrenia (94)
Series A (161)
Series B (110)
Service/supplier (12)
Sickle cell disease (63)
Special edition (19)
Spinal muscular atrophy (151)
Sponsored (33)
Startups (3739)
State (2)
Stomach cancer (15)
Supply chain (77)
Tariffs (63)
The Weekly (59)
Vaccines (803)
Venture capital (54)
Weight loss (276)
Women's health (47)
Worklife (16)
Date
Today (76)
Last 7 days (345)
Last 30 days (1871)
Last 365 days (31687)
2025 (17166)
2024 (35778)
2023 (40639)
2022 (51806)
2021 (56340)
2020 (54797)
2019 (47414)
2018 (35780)
2017 (33157)
2016 (32671)
2015 (38639)
2014 (32559)
2013 (27685)
2012 (29774)
2011 (30515)
2010 (28525)
Location
Africa (786)
Alabama (61)
Alaska (7)
Arizona (251)
Arkansas (14)
Asia (41143)
Australia (6573)
California (7499)
Canada (2382)
China (696)
Colorado (323)
Connecticut (321)
Delaware (195)
Europe (88111)
Florida (1128)
Georgia (248)
Hawaii (1)
Idaho (59)
Illinois (655)
India (28)
Indiana (370)
Iowa (17)
Japan (237)
Kansas (109)
Kentucky (29)
Louisiana (14)
Maine (64)
Maryland (1036)
Massachusetts (5614)
Michigan (248)
Minnesota (455)
Mississippi (3)
Missouri (90)
Montana (28)
Nebraska (25)
Nevada (81)
New Hampshire (66)
New Jersey (2100)
New Mexico (29)
New York (2104)
North Carolina (1103)
North Dakota (8)
Northern California (3296)
Ohio (237)
Oklahoma (16)
Oregon (39)
Pennsylvania (1626)
Puerto Rico (17)
Rhode Island (36)
South America (1165)
South Carolina (35)
South Dakota (1)
Southern California (2807)
Tennessee (126)
Texas (1137)
United States (27907)
Utah (222)
Virginia (198)
Washington D.C. (72)
Washington State (643)
West Virginia (4)
Wisconsin (69)
725,185 Results for "boehringer ingelheim pharmaceuticals inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Boehringer Ingelheim Harnesses GenAI to Transform Case Intake with LifeSphere® NavaX™
July 8, 2025
·
2 min read
Press Releases
Boehringer Ingelheim and Eko Health Inc. enter digital health collaboration to improve heart murmur detection in dogs
June 10, 2025
·
4 min read
Collaboration
Boehringer Ingelheim Expands Cancer Pipeline With Back-to-Back Antibody Deals
On Thursday, Boehringer Ingelheim announced a partnership with Synaffix to advance antibody-drug conjugates and exercised its fourth license option under a 2013 collaboration with Oxford BioTherapeutics.
January 10, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Lung Cancer Research Foundation Announces New Research Collaboration with Boehringer Ingelheim
June 17, 2025
·
6 min read
Press Releases
Boehringer Ingelheim Pharmaceuticals, Inc. Welcomes Brian Hilberdink as President, U.S. Human Pharma
February 20, 2025
·
2 min read
Press Releases
Boehringer Ingelheim initiates Phase II study of BI 1815368, a potential first-in-class oral treatment for diabetic macular edema
July 8, 2025
·
5 min read
Press Releases
Boehringer Ingelheim Showcases Bold Vision for the Future of Cancer Care at ASCO 2025
May 23, 2025
·
14 min read
Press Releases
Echosens and Boehringer Ingelheim Expand Long-Standing Collaboration to Accelerate Progress in MASH Diagnosis and Care
June 10, 2025
·
4 min read
Press Releases
Oxford BioTherapeutics Announces Third Oncology Drug Candidate from Boehringer Ingelheim Collaboration Selected to Advance into IND-Enabling Studies
July 3, 2025
·
3 min read
Drug Development
Boehringer Ingelheim’s Lung Fibrosis Drug Scores Second Late-Stage Win
Nerandomilast, an oral phosphodiesterase 4B inhibitor, hit the primary endpoint in a Phase III trial in progressive pulmonary fibrosis—nearly six months after achieving a similar feat in idiopathic pulmonary fibrosis. Boehringer plans to submit for FDA and other global approvals in both indications.
February 10, 2025
·
2 min read
·
Heather McKenzie
1 of 72,519
Next
